Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Regulatory News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
71.50    1.50 (2.14%)
Bid:
71.00
Ask:
72.00
Spread: 1.00 (1.408%)
Market Cap: £325.40m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Holding(s) in Company

30 May 2014 16:37

RNS Number : 5167I
Avacta Group PLC
30 May 2014
Β 

ο»Ώ

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Avacta Group Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Baillie Gifford & Co

4. Full name of shareholder(s) Β (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

29 May 2014

6. Date on which issuer notified:

30 May 2014

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

Β 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Β 

Ordinary Shares

GB0033519546

Below 5%

Below 5%

254,545,450

254,545,450

5.12%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

Β 

% of voting rights xix, xx

Β 

Β 

Β 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

254,545,450

5.12%

Β 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

In the narrative below, the figures in [ ] indicate the amount of voting rights and the percentage held by each controlled undertaking where relevant.

Β 

Baillie Gifford & Co, a discretionary investment manager, is the parent undertaking of an investment management group.

Β 

Its wholly-owned subsidiary undertaking Baillie Gifford & Co Limited [163,636,361:3.29%] is an OEIC Authorised Corporate Director and Unit Trust Manager which has delegated its discretionary investment management role to Baillie Gifford & Co.

Β 

Β 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Gillian Wright

15. Contact telephone number:

Β 

0131 275 3041

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLFMGFKKGDGDZM
Date   Source Headline
17th Oct 20137:00 amRNSFirst therapeutic licensing agreement for Affimers
26th Sep 20137:00 amRNSLaunch of Sensipod - First Point of Care Test
18th Sep 20137:00 amRNSIssue of Equity and Notice of Preliminary Results
16th Sep 20137:00 amRNSNew Head of R&D Joins Avacta
2nd Sep 20135:47 pmRNSTR-1 Notification of Major Interest in Shares
29th Aug 20137:00 amRNSPre-close trading update
28th Aug 20137:00 amRNSIssue of Equity
9th Aug 20138:35 amRNSTR-1: Notification of Major Interest in Shares
7th Aug 20135:51 pmRNSTR-1: Notification of Major Interest in Shares
7th Aug 20134:31 pmRNSTR-1: Notification of Major Interest in Shares
7th Aug 20134:30 pmRNSTR-1: Notification of Major Interest in Shares
7th Aug 20134:00 pmRNSTR-1: Notification of Major Interest in Shares
5th Aug 201311:00 amRNSResult of General Meeting
5th Aug 20137:00 amRNSAppointment of a Non-Executive Director
25th Jul 20137:00 amRNSExpansion of Collaboration with ForteBio
18th Jul 20137:00 amRNSConditional Placing to Raise £4.7 Million
23rd May 20138:40 amRNSHolding(s) in Company
30th Apr 20137:00 amRNSInterim Results
23rd Apr 20137:01 amRNSNotice of Interim Results
23rd Apr 20137:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20137:00 amRNSInterest in Affimer Technology
27th Feb 20137:00 amRNSBusiness Update
18th Feb 20135:08 pmRNSAdditional Listing
25th Jan 20132:34 pmRNSResult of AGM
21st Jan 20131:20 pmRNSHolding(s) in Company
7th Jan 20133:47 pmRNSHolding(s) in Company
23rd Oct 20127:00 amRNSPreliminary Results
24th Sep 20127:00 amRNSAvacta and Pall extend Optim distribution to India
13th Sep 201210:24 amRNSNotice of Preliminary Results
24th Aug 20127:00 amRNSPre-close trading update
19th Jun 20125:05 pmRNSHolding(s) in Company
25th Apr 20127:00 amRNSInterim Results
2nd Apr 20127:00 amRNSAvacta Signs Exclusive Supply Deal with IDEXX
15th Mar 20127:00 amRNSNotice of Interim Results
24th Jan 201210:39 amRNSResult of AGM
19th Jan 20126:23 pmRNSHolding(s) in Company
12th Jan 201211:12 amRNSHolding(s) in Company
10th Jan 20129:26 amRNSCompletes £5.13m placing and Aptuscan acquisition
9th Jan 20124:10 pmRNSResults of General Meeting
22nd Dec 20117:00 amRNSConditional Placing and Proposed Acquisition
8th Dec 20112:20 pmRNSNotice of AGM and Report and Accounts
25th Nov 20117:00 amRNSAdditional Listing & Total Voting Rights
25th Oct 20117:00 amRNSPreliminary Results
21st Oct 20117:00 amRNSAppointment of Nomad and Broker
5th Oct 20117:00 amRNSSouth East Asian Alliance agreed with Pall
19th Sep 20117:00 amRNSNotice of Preliminary Results
9th Aug 20117:00 amRNSPre-close Trading Update
6th Jul 20117:00 amRNSChange of Registered Office
10th Jun 201112:50 pmRNSDirector/PDMR Shareholding
31st May 20117:00 amRNSAvacta secures second Optim sale in US

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.